Eosinophilia and Cell Activation Mediators in Nasal Secretions
暂无分享,去创建一个
[1] M. Lindsay,et al. Pharmacology of the eosinophil. , 1999, Pharmacological reviews.
[2] M. Béné,et al. Microparticle-enhanced nephelometric immunoassay of lysozyme in milk and other human body fluids. , 1998, Clinical chemistry.
[3] E. Nemoto,et al. Heterogeneous Expression and Release of CD14 by Human Gingival Fibroblasts: Characterization and CD14-Mediated Interleukin-8 Secretion in Response to Lipopolysaccharide , 1998, Infection and Immunity.
[4] R. Jankowski. Eosinophils in the pathophysiology of nasal polyposis. , 1996, Acta oto-laryngologica.
[5] R. Braun,et al. Human peripheral blood eosinophils produce and release interleukin‐8 on stimulation with calcium ionophore , 1993, European journal of immunology.
[6] B. Finlay,et al. Soluble CD14 participates in the response of cells to lipopolysaccharide , 1992, The Journal of experimental medicine.
[7] R. Ulevitch,et al. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.
[8] H. Reynolds,et al. Macrophages and polymorphonuclear neutrophils in lung defense and injury. , 1990, The American review of respiratory disease.
[9] K. Matsushima,et al. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1). , 1987, Journal of immunology.